- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Gentoo Linux Security Advisory GLSA 201311-01 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - http://security.gentoo.org/ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Severity: Normal Title: Mednafen: Arbitrary code execution Date: November 04, 2013 Bugs: #326141 ID: 201311-01 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Synopsis ======== An unspecified vulnerability in Mednafen could result in the execution of arbitrary code. Background ========== Mednafen is an advanced NES, GB/GBC/GBA, TurboGrafx 16/CD, NGPC and Lynx emulator. Affected packages ================= ------------------------------------------------------------------- Package / Vulnerable / Unaffected ------------------------------------------------------------------- 1 games-emulation/mednafen < 0.8.13 >= 0.8.13 Description =========== An unspecified vulnerability has been discovered in Mednafen when using network play. Impact ====== A remote server could execute arbitrary code with the privileges of the process. Workaround ========== There is no known workaround at this time. Resolution ========== All Mednafen users should upgrade to the latest version: # emerge --sync # emerge --ask --oneshot -v ">=games-emulation/mednafen-0.8.13" References ========== [ 1 ] CVE-2010-3085 http://nvd.nist.gov/nvd.cfm?cvename=CVE-2010-3085 Availability ============ This GLSA and any updates to it are available for viewing at the Gentoo Security Website: http://security.gentoo.org/glsa/glsa-201311-01.xml Concerns? ========= Security is a primary focus of Gentoo Linux and ensuring the confidentiality and security of our users' machines is of utmost importance to us. Any security concerns should be addressed to security@gentoo.org or alternatively, you may file a bug at https://bugs.gentoo.org. License ======= Copyright 2013 Gentoo Foundation, Inc; referenced text belongs to its owner(s). The contents of this document are licensed under the Creative Commons - Attribution / Share Alike license. http://creativecommons.org/licenses/by-sa/2.5